MedTrace Logo

Lomatuell Pro® Versus UrgoTul® in the Management of Acute Wounds

NCT03897465 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2025-10-29

Study results available
· View outcomes & findings →

Summary

Comparative evaluation of the propertieS of the contact LAyer dressing LOMatuell Pro® versus UrgoTul® in the management of acute wounds

Conditions

  • Acute Wounds

Interventions

DEVICE

Lomatuell Pro

Patients will receive Lomatuell Pro dressings during 3 weeks. Lomatuell Pro® may be left in place up to 7 days; additional dressing changes can be performed as often as necessary according to the instruction for use.

DEVICE

UrgoTul

Patients will receive UrgoTul dressings during 3 weeks. UrgoTul® may be left in place up to 7 days; ; additional dressing changes can be performed as often as necessary according to the instruction for use.

Sponsors & Collaborators

  • RCTs

    collaborator INDUSTRY

  • Lohmann & Rauscher

    lead INDUSTRY

Principal Investigators

  • Daria TROFIMENKO · Lohmann & Rauscher

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-11
Primary Completion
2020-12-06
Completion
2020-12-06

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03897465 on ClinicalTrials.gov